MongoDB director reports 31,000-share sale; holdings remain over 1.6M shares
Rhea-AI Filing Summary
Dwight A. Merriman, a MongoDB, Inc. (MDB) director, reported multiple sales of Class A common stock on 09/19/2025 executed under a Rule 10b5-1 trading plan. The Form 4 discloses seven sale entries totaling 31,000 shares sold at weighted-average prices ranging roughly from $318.08 to $322.84 across the separate transactions. After the reported transactions, the filing shows 1,079,316 shares beneficially owned directly by the reporting person, 514,896 shares held indirectly by a trust for his children, and 83,845 shares held by the Dwight A. Merriman Charitable Foundation (over which he has voting and investment power but no pecuniary interest).
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating preplanned, compliant insider sales.
- Detailed disclosure of weighted-average prices and the nature of indirect holdings (trust and charitable foundation).
- Significant remaining holdings disclosed: 1,079,316 shares direct, 514,896 held by trust, and 83,845 held by the charitable foundation.
Negative
- Insider disposed of 31,000 Class A shares on 09/19/2025, which reduces direct economic exposure.
- Sales spanned price ranges from about $318.08 to $322.84, implying multiple executions rather than a single-block sale.
Insights
TL;DR Insider sold 31,000 MDB shares under a 10b5-1 plan; holdings remain sizable with both direct and indirect ownership.
The reported sale of 31,000 Class A shares on 09/19/2025 was executed pursuant to an established Rule 10b5-1 trading plan, with weighted-average prices reported in the filing and per-footnote ranges between approximately $318.08 and $322.84. The reporting person retains substantial ownership: 1,079,316 shares directly and additional indirect holdings through a trust (514,896) and a charitable foundation (83,845). For investors, this is a transparent disclosure of scheduled insider liquidity rather than an unscheduled disposition; the filing does not present any additional financial metrics or company guidance.
TL;DR Sales were made under a documented 10b5-1 plan and were properly disclosed on Form 4, preserving compliance norms.
The Form 4 indicates the transactions were covered by a 10b5-1 plan, which provides an affirmative defense to insider trading allegations when conditions are met. The filing includes granular footnotes about weighted-average prices and the nature of indirect holdings (trust for children and charitable foundation). The signature by an attorney-in-fact is dated 09/23/2025, completing the required disclosure formalities. No amendments or indications of unscheduled or suspicious trades are stated in the document.
FAQ
What insider transactions did MDB director Dwight A. Merriman report on 09/19/2025?
At what prices were the MDB shares sold in the reported transactions?
How many MDB shares does Dwight A. Merriman beneficially own after the reported sales?
Were the sales part of a 10b5-1 plan?
Who signed the Form 4 filing for these transactions?